"Can Building Muscle Reduce Death Risk in Fatty Liver Disease? Fight MAFLD & Sarcopenia"
Worried about fatty liver disease (MAFLD)? New research suggests building muscle may lower your mortality risk. Learn how to combat MAFLD and muscle loss (sarcopenia) for a longer, healthier life.
DR ANITA JAMWAL MS
7/6/20246 min read
A recent study published in Nutrition & Diabetes has uncovered a troubling link between metabolic dysfunction-associated fatty liver disease (MAFLD) and muscle loss (sarcopenia), highlighting their combined effect on mortality risk. People with either MAFLD or sarcopenia were found to have a higher chance of death compared to those without. However, the most concerning aspect is the synergistic effect. When both conditions coexist, mortality risk worsens significantly, suggesting a combined impact greater than the sum of their individual effects. The study also revealed a link between MAFLD and sarcopenia and a higher risk of developing severe liver scarring (fibrosis). This suggests that sarcopenia may worsen this complication of MAFLD. Diagnosing MAFLD involves ultrasound detection of liver fat and the presence of at least one of these factors: overweight/obesity, diabetes, or metabolic abnormalities. To determine muscle mass, sarcopenia is assessed using a bioelectrical impedance analysis (BIA) test and height measurements. These findings highlight the importance of early detection and management of MAFLD and sarcopenia. Treatment strategies for MAFLD might need to incorporate methods to improve muscle mass and function in patients with co-existing sarcopenia.
Key Points
Double Whammy: Both MAFLD (fatty liver disease) and sarcopenia (muscle loss) are independently linked to a higher risk of death.
Synergistic Effect: Having both MAFLD and sarcopenia significantly worsens mortality risk compared to either condition alone. This suggests a combined effect greater than the sum of their individual impacts.
Liver Fibrosis Risk: MAFLD with sarcopenia is associated with a higher chance of developing severe liver scarring (fibrosis). Sarcopenia appears to worsen this complication of MAFLD.
MAFLD Diagnosis: Ultrasound-detected liver fat and the presence of at least one of these factors: overweight/obesity, diabetes, or metabolic issues.
Sarcopenia Assessment: Bioelectrical impedance analysis (BIA) test and height measurements to determine muscle mass. A sex-specific threshold is used to identify sarcopenia.
Large-Scale Study: The research used data from a major US national survey, strengthening the analysis of the MAFLD-sarcopenia-mortality connection.
Call to Action: Early detection and management of MAFLD and sarcopenia are crucial. Treatment strategies for MAFLD might need to address muscle loss in patients with co-existing sarcopenia. Further research is needed to explore the underlying mechanisms and develop targeted therapies for this high-risk group.
Fatty Liver Disease, Muscle Loss, and Mortality Risk: A Double Whammy?
Fatty liver disease, particularly metabolic dysfunction-associated fatty liver disease (MAFLD), and muscle loss (sarcopenia) are both on the rise globally. These conditions are not just independent health concerns; recent research suggests they can create a dangerous double whammy, significantly increasing the risk of death. This blog post dives into this emerging area of study, exploring the link between MAFLD, sarcopenia, and mortality.
Understanding MAFLD and Sarcopenia
MAFLD: Imagine your liver, the body's powerhouse for processing nutrients and filtering toxins, overloaded with fat. This is the hallmark of MAFLD, a condition where excess fat builds up in the liver, even in people who don't drink excessively. Unlike NAFLD (non-alcoholic fatty liver disease), MAFLD diagnosis doesn't require excluding other potential causes of liver fat. Importantly, MAFLD is linked to various health problems, including:
Insulin resistance and type 2 diabetes
Increased cardiovascular disease risk
Liver fibrosis and even cirrhosis (severe scarring)
Sarcopenia: As we age, it's natural to lose muscle mass. However, sarcopenia refers to an accelerated and concerning loss of muscle strength and function. It can significantly impact mobility, daily activities, and overall health. People with sarcopenia are more prone to:
Falls and fractures
Difficulty performing everyday tasks
Increased risk of hospitalization
The Troubling Connection Between MAFLD and Sarcopenia
Recent studies, including a large-scale analysis from the National Health and Nutrition Examination Surveys (NHANES) in the US, reveal a worrying link between MAFLD and sarcopenia. Here's what the research suggests:
Both MAFLD and sarcopenia independently increase mortality risk. This means that people with either condition have a higher chance of death compared to those without.
The presence of both MAFLD and sarcopenia creates an additive effect, significantly worsening mortality risk. In simpler terms, having both conditions together substantially increases the likelihood of death.
MAFLD with sarcopenia is associated with a higher risk of liver fibrosis. This is a serious complication of MAFLD, where healthy liver tissue is replaced by scar tissue, hindering its function. Sarcopenia seems to exacerbate this risk.
Results
Prevalence and Demographics:
The study included 13,692 participants with a mean age of 43.7 years, 47.3% of whom were male.
MAFLD (Metabolic Dysfunction-Associated Fatty Liver Disease) was diagnosed in 30.73% of participants (4,207 individuals).
Among those with MAFLD, 19.42% were found to have sarcopenia, defined by weight-adjusted skeletal muscle mass.
Mortality and Risk Factors:
Both MAFLD and sarcopenia were independently associated with increased all-cause mortality after adjusting for factors such as age, sex, race, marital status, education, and smoking.
The mean follow-up duration was 23.7 years, during which mortality rates were analyzed.
Combined Effects of MAFLD and Sarcopenia:
Individuals with both MAFLD and sarcopenia had a significantly higher risk of mortality compared to those without these conditions.
The presence of both conditions additively increased the mortality risk, highlighting the combined detrimental impact of MAFLD and sarcopenia.
Liver Fibrosis:
MAFLD and sarcopenia together were significantly associated with higher risks of liver fibrosis.
Assessed using the NAFLD Fibrosis Score (NFS) and Fibrosis-4 (FIB-4) index, individuals with both conditions had higher odds of significant liver fibrosis
Why This Matters
These findings highlight the importance of a comprehensive approach to managing both MAFLD and sarcopenia. Here's why:
Early detection is key. Identifying and addressing both conditions early can potentially prevent complications and improve overall health outcomes.
Treatment strategies need to consider the combined risk. Current therapies for MAFLD often focus on diet, exercise, and weight management. However, incorporating strategies to improve muscle mass and function might be crucial for patients with co-existing sarcopenia.
More research is needed. While the link between MAFLD, sarcopenia, and mortality is becoming clearer, further investigation is needed to understand the underlying mechanisms and develop targeted treatment approaches for this high-risk patient population.
Taking Charge of Your Health
If you're concerned about MAFLD, sarcopenia, or both, here are some steps you can take:
Talk to your doctor. Discuss your risk factors and get screened for both conditions. Early detection is crucial for effective management.
Embrace a healthy lifestyle. A balanced diet rich in fruits, vegetables, and whole grains, combined with regular physical activity, is essential for both MAFLD and sarcopenia prevention and management.
Focus on strength training. Building and maintaining muscle mass is vital for overall health and can help combat sarcopenia. Consider incorporating weight training or resistance exercises into your routine, even if you're starting from scratch. Your doctor or a certified trainer can guide you on safe and effective exercises.
Maintain a healthy weight. Excess weight is a risk factor for both MAFLD and sarcopenia. Aim for a healthy weight range through a combination of diet and exercise.
Manage other health conditions. Underlying health issues like diabetes and high blood pressure can contribute to both MAFLD and sarcopenia. Work with your doctor to effectively manage any existing conditions.
Remember, you're not alone. MAFLD and sarcopenia are increasingly common conditions. By taking a proactive approach to managing your health, you can empower yourself to reduce risks and live a longer, healthier life. Don't hesitate to discuss your concerns with your doctor and explore treatment options that address both conditions.
What is MAFLD?
MAFLD (metabolic dysfunction-associated fatty liver disease) is a condition where excess fat builds up in the liver, even in people who don't drink excessively. Unlike NAFLD (non-alcoholic fatty liver disease), MAFLD diagnosis doesn't require excluding other potential causes of liver fat. It's linked to health problems like diabetes, heart disease, and severe liver complications.
What are the symptoms of MAFLD?
MAFLD often has no noticeable symptoms in its early stages. However, some people may experience fatigue, upper right abdominal pain, or unexplained weight loss.
What causes sarcopenia?
Several factors contribute to sarcopenia, including aging, inactivity, malnutrition, and certain chronic illnesses. As we age, muscle mass naturally decreases. Lack of exercise and a poor diet further accelerate muscle loss. Additionally, some medical conditions can interfere with muscle protein synthesis, leading to sarcopenia
How is sarcopenia diagnosed?
Doctors typically diagnose sarcopenia by assessing muscle mass and strength. This can involve bioelectrical impedance analysis (BIA) tests, dual-energy X-ray absorptiometry (DXA) scans, and physical strength tests like handgrip strength measurement.
Can sarcopenia be reversed?
While complete reversal may not always be possible, muscle loss can be slowed down and even partially reversed through a combination of strength training exercises and a healthy diet rich in protein.
How can I prevent MAFLD and sarcopenia?
Maintaining a healthy lifestyle is key to preventing both conditions. This includes:
Healthy diet: Focus on fruits, vegetables, whole grains, and lean protein. Limit saturated and unhealthy fats, added sugars, and processed foods.
Regular exercise: Engage in both aerobic activity and strength training exercises to maintain muscle mass and improve overall health.
Weight management: Aim for a healthy weight and avoid obesity
Should I be worried if I have both MAFLD and sarcopenia?
Yes, having both conditions increases your risk of complications and mortality. If you suspect you might have either MAFLD or sarcopenia, consult your doctor for proper diagnosis and discuss treatment options. Early detection and management are crucial for improving your long-term health.
Journal Reference
Zhao, Q., Yin, Y., & Deng, Y. (2023). Metabolic associated fatty liver disease and sarcopenia additively increase mortality: A real-world study. Nutrition & Diabetes, 13(1), 1-7. https://doi.org/10.1038/s41387-023-00250-6
Image credit: https://www.frontiersin.org/files/Articles/592373/fendo-11-592373-HTML/image_m/fendo-11-592373-g004.jpg
Related
https://healthnewstrend.com/b-vitamins-for-muscle-health-can-they-help-fight-early-sarcopenia
https://healthnewstrend.com/chronic-kidney-disease-how-uric-acid-levels-impact-heart-health
Disclaimer
The information on this website is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.